About us

Quantify is an experienced partner in health economics, outcomes research, real-world evidence and market access. We provide services in value strategy, modelling, reimbursement support, evidence generation, biostatistics, study design and analysis.

Quantify history

Our history

The company was founded in 2011, and is led by the founding partners and our CEO; each with 8 to 16 years’ experience from HEOR, both from other consultancies, the pharmaceutical industry and research at the Karolinska Institute.

We have provided consultancy services and advice to most large pharmaceutical companies, as well as to numerous regional, national and international organizations and governmental bodies. We primarily cover Europe and North America.


Our goals

  • Be our clients’ first choice for health economics, outcomes research and real-world evidence services, because we continuously deliver excellent services, which meet the needs of our client.
  • Drive innovation, by developing new solutions in the HEOR field and being active in the scientific community, and also enable better quality and efficiency in healthcare by supporting informed decision making.
  • Be the most attractive research company for current and future colleagues, because we offer a stimulating environment to personally and collectively develop and excel in what we do.

Services offered

We have the expertise and experience to identify, quantify and communicate the value of health care interventions and reforms. With our technical and innovative ability, we are able to design and execute any type of project in the area of health economics, outcomes research, real-world evidence and market access.

Our experience covers a wide range of methodological and geographical areas. Furthermore, we have extensive expertise in a large number of therapeutic areas, including e.g. neuroscience, oncology, musculoskeletal, inflammatory and cardiovascular diseases.

Read more


What makes us unique

Our experienced partners are active in the everyday business, contributing with methodological and strategic guidance to make each project successful and assure high quality. Every client is important to us; we don’t apply a standard solution to projects, but strive to meet the individual needs and be a valuable discussion partner. Our organization is lean and flexible, and customers express satisfaction with resulting quick turnaround times and direct communication.

We continuously develop new knowledge and competence in the HEOR field, by being active researchers and building excellent academic networks.

A competent and dedicated team

Biographies of the leadership team

Kirk Geale, MSc, PhDc
Partner, CEO

Kirk Geal portrait

Kirk is the CEO of Quantify Research and serves on its Board of Directors. He is currently a PhD candidate at the Department of Public Health and Clinical Medicine at Umeå University (Sweden), where he studies psoriasis patients’ clinical and economic outcomes using observational registry data. He holds a MSc from Lund University (Sweden) in Economics, specializing in econometrics. He also holds a Bachelor of Commerce in Management Economics in Industry and Finance from the Gordon S. Lang School of Business and Economics at Guelph University (Canada).

He has 10 years’ of international work experience in health economics and outcomes research (HEOR) at Quantify Research, Parexel International, and in academia. Kirk has hands-on experience in a variety of areas including real-world evidence generation, economic modelling, value demonstration in health technology assessment and evidence synthesis. Kirk is active in the research community and regularly lectures at industry and academic conferences. His disease area expertise spans dermatology, respiratory, immunology, women’s health, central nervous system, and musculoskeletal.

Fredrik Borgström, MSc, PhD

Dr Fredrik Borgström, MSc, PhD, is one of the co-founders of Quantify and currently chairman of the board. He has over 20 years’ experience in providing consultancy services to industry, private and public organizations and institutions within the field of health economics and outcomes research, real world evidence and market access.

Previous to starting Quantify, he was managing the Swedish operations Fredrik at i3 Innovus. where he managed the Swedish operations. Fredrik has been involved in projects in several disease areas, including osteoporosis, rheumatoid arthritis, osteoarthritis, oncology, multiple sclerosis, menopausal symptoms and cardiovascular disease.

Fredrik has been author of more than 100 articles published in scientific journals. His research covers methods such as modeling, data collection and statistical analysis of retrospective and prospective data.

Oskar Ström, MSc, PhD

Dr. Oskar Ström is one of Quantify’s co-founders and sits on the board of directors. He is a registered pharmacist with a Master’s degree in pharmaceutical bioscience from Uppsala University and has a PhD in pharmacoepidemiology from Karolinska Institutet, Sweden. Oskar has extensive experience in health economics, and retrospective and prospective study design and analysis.

Oskar has 17 years’ experience as a consultant to industry, private and public organizations and institutions in the field of health economics and outcomes research. He has worked in a wide range of areas, including osteoporosis, hip arthroplasty, rheumatoid arthritis, postmenopausal symptoms, glaucoma, migraine, asthma, liver disease, spine surgery, and treatment adherence and provision. He has been lead author and co-author of over 50 peer-reviewed manuscripts and has presented at several scientific conferences.

Oskar is an affiliated researcher at the departement of medicine at Karolinska Institutet, focusing on retrospective research in Chronic Liver Disease.

Anders Gustavsson, MSc, PhD